Meerten, E. van

patient cancer study treatment chemotherapy esophageal surgery survival j clin oncol chemoradiotherapy carcinoma oesophageal oesophageal cancer trial oncol esophageal cancer score preoperative radiotherapy response phase neoadjuvant resection cell carcinoma esophagus therapy tumor quality effect randomized adenocarcinoma month neoadjuvant chemoradiotherapy phase ii study cisplatin grade tumour patien toxicity paclitaxel chemoradiation esophageal carcinoma eur j cancer disease baseline preoperative chemoradiotherapy result fluorouracil randomised radiation chapter preoperative chemotherapy resectable analysis lymph resectable esophageal cancer metastatic carboplatin symptom oesophagu j surg oncol lymph nodes difference factor 5- fluorouracil tumor cells questionnaire behandeling follow-up hrqol 2002. number dysphagia capecitabine postoperatively 2001. slokdarmkanker 2003. regimen review